BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29

• FDA

  Boston Scientific Bags CE Mark for Eluvia Peripheral Stent

  February 22, 2016

   · 

  7 min read
• FDA

  Lannett Receives FDA Approval For Sumatriptan Nasal Spray USP, 5mg And 20mg

  February 22, 2016

   · 

  2 min read
• Drug Development

  Braeburn Pharma And Camurus Announce Initiation Of A Phase 2 Study In Opioid Dependent Patients With Moderate To Severe Chronic Pain

  February 22, 2016

   · 

  4 min read
• Policy

  Medicare Contractor Will Not Cover St. Jude Medical’s Cardiomems Heart Monitor

  February 22, 2016

   · 

  1 min read
• Biotech Bay

  ReCor Medical Announces IDE Approval For RADIANCE-HTN Hypertension Clinical Trial

  February 22, 2016

   · 

  3 min read
• Business

  PHARNEXT Announces The Appointment Of Niall Murphy As Chief Scientific Officer And Pierre Schwich As Chief Financial Officer

  February 22, 2016

   · 

  3 min read
• Drug Development

  Mast Therapeutics Completes Patient Enrollment In Pivotal Phase 3 “EPIC” Study For The Treatment Of Sickle Cell Crisis

  February 22, 2016

   · 

  9 min read
• Drug Development

  OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial In Patients With Metastatic Breast Cancer

  February 22, 2016

   · 

  4 min read
• IMPACT Therapeutics, Inc. Announces Completion Of Around $10 Million Series B Financing

  February 22, 2016

   · 

  5 min read
• Pharm Country

  Echo Therapeutics Announces New Patents for Non-Invasive Sensing Technology

  February 22, 2016

   · 

  3 min read